Clinical Pharmacology Reviewer
FDA
Sojeong Yi, PhD, is a Clinical Pharmacology Reviewer in Center for Biologics Evaluation and Research (CBER) of U.S. Food and Drug Administration (FDA).
Dr. Yi joined FDA in 2016 serving as a Clinical Pharmacology Reviewer in Office of Clinical Pharmacology of Center for Drug Evaluation and Research (CDER) and she recently moved to Office of Therapeutic Product in CBER in 2023.
She majored in pharmacy at Ewha Womans University and received both an MS and a PhD in clinical pharmacology from Seoul National University in South Korea. Following her PhD, she worked as a clinical instructor and research fellow at Dong-A University Hospital and Seoul National University Hospital for four years before joining FDA.
Disclosure(s): No financial relationships to disclose
The Regulatory Landscape of Quantitative Pharmacology for New Therapeutic Modalities at the FDA
Sunday, November 10, 2024
12:45 PM – 1:45 PM MST
